Methadyne
Active substance
ATC code
Species
Dogs and cats.
Indications
• Analgesia.
• Premedication for general anaesthesia or neuroleptanalgesia in combination with a neuroleptic drug.
Dose to be administered and administration route
Before administration the body weight should be accurately determined.
Analgesia
Dogs: |
0.5 to 1 mg Methadone HCl per kg bodyweight, SC, IM or IV (corresponding to 0.05 to 0.1 ml/kg) |
Cats: |
0.3 to 0.6 mg Methadone HCl per kg bodyweight, IM (corresponding to 0.03 to 0.06 ml/kg) |
To ensure accuracy of dosing in cats, an appropriately calibrated syringe should be used to administer the product.
As the individual response to methadone is variable, and depends partly on the dosage, the age of the patient, individual differences in pain sensitivity and general condition, the optimal dosing regimen should be individually based.
In dogs, onset of action is 1 hour following subcutaneous administration, approximately 15 minutes following intramuscular injection and within 10 minutes following intravenous injection. Duration of effect is approximately 4 hours following intramuscular or intravenous administration.
In cats, following intramuscular injection, onset of action is 15 minutes, and the duration of effect is 4 hours on average.
The animal should be examined regularly to assess if additional analgesia is subsequently required.
Premedication and/or neuroleptanalgesia
Dogs:
• Methadone HCl 0.5-1 mg/kg bodyweight, IV, SC or IM
(corresponding to 0.05 to 0.1 ml/kg)
Combinations e.g.:
• Methadone HCl 0.5 mg/kg bodyweight, IV (corresponding to 0.05 ml/kg), + e.g.
midazolam or diazepam
Induction with propofol, maintenance with isoflurane in oxygen.
• Methadone HCl 0.5 mg/kg bodyweight, IV (corresponding to 0.05 ml/kg), + e.g. acepromazine
Induction with thiopentone or propofol to effect, maintenance with isoflurane in oxygen or induction with diazepam and ketamine.
• Methadone HCl 0.5 -1.0 mg/kg bodyweight, IV or IM (corresponding to 0.05 to
0.1 ml/kg), + α2-agonist (e.g. xylazine or medetomidine)
Induction with propofol, maintenance with isoflurane in oxygen, in combination with fentanyl or total intravenous anaesthesia (TIVA) protocol: maintenance with propofol in combination with fentanyl.
TIVA protocol: induction propofol, to effect. Maintenance with propofol and remifentanil.
Chemical-physical compatibility has only been demonstrated for dilutions 1:5 with the following solutions for infusion: sodium chloride 0.9%, Ringer’s solution, and glucose 5%.
Cats:
• Methadone HCl 0.3-0.6 mg/kg bodyweight, IM (corresponding to 0.03 to
0.06 ml/kg)
▪Induction with benzodiazepine (e.g. midazolam) and dissociative (e.g.ketamine).
▪With a tranquiliser (e.g. acepromazine) and NSAID (meloxicam) or sedative (e.g. α2-agonist).
▪Induction with propofol, maintenance with isoflurane in oxygen.
Doses are dependent on the desired degree of analgesia and sedation, desired duration of effect and the concurrent use of other analgesics and anaesthetics.
When used in combination with other products, lower dosages can be used. For safe use with other veterinary medicinal products, reference must be made to the relevant product literature.
Adverse reactions
In very common cases (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment), the following reactions have been observed after administration of the product:
Cats: Respiratory depression may be seen. Mild excitatory reactions have been observed: lip licking, vocalisation, urination, defaecation, mydriasis, hyperthermia and diarrhoea. Hyperalgesia has been reported. All reactions were transient.
Dogs: Respiratory depression and bradycardia may be seen. Mild reactions have been observed: panting, lip licking, salivation, vocalisation, irregular breathing, hypothermia, fixed stare and body tremors. Occasional urination and defaecation can be seen within the first hour post dose. All reactions were transient.